Outlook Therapeutics, Inc. (OTLK)

Outlook Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	32.02	23.39	17.4	14.48	12.54	8.02
Cash & Short-Term Investments	32.02	23.39	17.4	14.48	12.54	8.02
Cash Growth	-5.00%	34.46%	20.17%	15.49%	56.40%	366.73%
Other Receivables	-	-	-	-	0.8	1.2
Receivables	-	-	-	-	0.8	1.2
Prepaid Expenses	13.59	7.59	10.12	7.03	4.61	3.79
Other Current Assets	-	-	-	-	-	0.5
Total Current Assets	45.62	30.98	27.52	21.51	17.94	13.5
Property, Plant & Equipment	0.29	0.03	0.07	0.28	0.49	3.18
Long-Term Investments	0.71	0.79	0.8	0.85	0.9	-
Long-Term Deferred Charges	0.33	0.33	0.12	-	-	-
Other Long-Term Assets	0.15	0.17	0.01	0.17	0.39	0.46
Total Assets	47.09	32.3	28.53	22.81	19.73	17.13
Accounts Payable	5.55	6.57	3.49	2.2	2.39	2.28
Accrued Expenses	2.68	2.75	3.43	1.73	3.79	4.62
Current Portion of Long-Term Debt	32.43	35.55	10.92	0.9	3.66	11.34
Current Portion of Leases	0.03	0	0.04	0.07	0.22	0.19
Current Income Taxes Payable	1.86	1.86	1.86	1.86	1.86	1.86
Other Current Liabilities	-	-	-	-	3.97	-
Total Current Liabilities	42.55	46.73	19.73	6.75	15.89	20.29
Long-Term Debt	-	-	-	10.89	0.9	0.05
Long-Term Leases	0.26	-	0	0.04	0.04	3.37
Other Long-Term Liabilities	87.95	0.01	0.06	0.52	0.07	4.2
Total Liabilities	130.77	46.74	19.79	18.2	16.91	27.9
Common Stock	0.23	2.6	2.27	1.76	1.27	0.29
Additional Paid-In Capital	465.07	450.88	415.4	345.73	291.27	238.06
Retained Earnings	-548.98	-467.92	-408.94	-342.88	-289.72	-254.48
Total Common Equity	-83.67	-14.44	8.74	4.61	2.83	-16.13
Shareholders' Equity	-83.67	-14.44	8.74	4.61	2.83	-10.77
Total Liabilities & Equity	47.09	32.3	28.53	22.81	19.73	17.13
Total Debt	32.72	35.56	10.96	11.9	4.83	14.95
Net Cash (Debt)	-0.7	-12.16	6.44	2.57	7.71	-6.93
Net Cash Growth	-	-	150.06%	-66.60%	-	-
Net Cash Per Share	-0.04	-0.97	0.61	0.34	2.13	-7.62
Filing Date Shares Outstanding	23.66	13.01	11.41	11.21	6.36	1.51
Total Common Shares Outstanding	23.41	13.01	11.37	8.82	6.36	1.43
Working Capital	3.06	-15.75	7.79	14.76	2.06	-6.79
Book Value Per Share	-3.57	-1.11	0.77	0.52	0.44	-11.28
Tangible Book Value	-83.67	-14.44	8.74	4.61	2.83	-16.13
Tangible Book Value Per Share	-3.57	-1.11	0.77	0.52	0.44	-11.28
Machinery	-	-	-	1.07	1.07	1.07
Leasehold Improvements	-	-	-	-	-	0.16

Source: S&P Capital IQ. Standard template. Financial Sources.